A clinical prediction model identifies a subgroup with inferior survival within intermediate risk acute myeloid leukemia.
Hu X, Wang B, Chen Q, Huang A, Fu W, Liu L, Zhang Y, Tang G, Cheng H, Ni X, Gao L, Chen J, Chen L, Zhang W, Yang J, Cao S, Yu L, Wang J.
Hu X, et al.
J Cancer. 2021 Jun 11;12(16):4912-4923. doi: 10.7150/jca.57231. eCollection 2021.
J Cancer. 2021.
PMID: 34234861
Free PMC article.